Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus: a Multicenter Randomized Controlled Trial

NCT07383779 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.

NCT NCT07383779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07383779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus: a Multicenter Randomized Controlled Trial
Lead sponsor
Versailles Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
June 1, 2029
Enrollment
466 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

convulsive refractory status epilepticus, status epilepticus